Bionime Corporation (TPE:4737)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotech Department	1.84B	1.93B	1.76B	2.21B	1.85B
Biotech Department Growth	-4.92%	10.15%	-20.58%	19.50%	10.87%
Total	1.84B	1.93B	1.76B	2.21B	1.85B
Total Growth	-4.92%	10.15%	-20.58%	19.50%	10.87%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Algeria	530.60M	550.95M	340.85M	728.55M	141.81M
Algeria Growth	-3.69%	61.64%	-53.22%	413.75%	-43.61%
China	184.76M	230.94M	251.85M	299.29M	329.83M
China Growth	-20.00%	-8.30%	-15.85%	-9.26%	89.97%
United States	134.55M	170.98M	204.38M	177.30M	190.93M
United States Growth	-21.30%	-16.34%	15.27%	-7.14%	7.48%
Republic of Belarus	88.69M	105.50M	68.62M	-	-
Republic of Belarus Growth	-15.94%	53.76%	-	-	-
United Arab Emirates	24.55M	38.07M	88.88M	26.98M	-
United Arab Emirates Growth	-35.52%	-57.17%	229.40%	-	-
Switzerland	38.11M	57.28M	101.64M	136.45M	234.48M
Switzerland Growth	-33.47%	-43.64%	-25.51%	-41.81%	-0.43%
Egypt	15.55M	23.85M	18.63M	31.31M	76.25M
Egypt Growth	-34.81%	28.01%	-40.49%	-58.94%	-21.23%
Other Countries	821.79M	756.18M	680.72M	810.71M	876.62M
Other Countries Growth	8.68%	11.08%	-16.03%	-7.52%	19.50%
Total	1.84B	1.93B	1.76B	2.21B	1.85B
Total Growth	-4.92%	10.15%	-20.58%	19.50%	10.87%

Source: S&P Global Market Intelligence.